Wrapmanager Inc Eli Lilly & CO Transaction History

Wrapmanager Inc

$375 Million
Q1 2025

A detailed history of Wrapmanager Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wrapmanager Inc holds 3,117 shares of LLY stock, worth $2.52 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

3,117

Previous 2,976 4.74%

Holding current value

$2.52 Million

Previous $2.3 Million 12.06%

% of portfolio

0.69%

Previous 0.6%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$725.72 - $929.72 $102,326 - $131,090	141 Added 4.74%	3,117 $2.57 Million
Q4 2024 Feb 04, 2025	BUY	$727.2 - $932.06 $309,060 - $396,125	425 Added 16.66%	2,976 $2.3 Million
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $98,833 - $122,882	128 Added 5.28%	2,551 $2.26 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $141,349 - $177,262	195 Added 8.75%	2,423 $2.19 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $211,415 - $282,843	357 Added 19.08%	2,228 $1.73 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $29,935 - $35,290	-57 Reduced 2.96%	1,871 $1.09 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $208,656 - $287,664	480 Added 33.15%	1,928 $1.04 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $13,678 - $18,290	-39 Reduced 2.62%	1,448 $679,000
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $15,220 - $17,876	49 Added 3.41%	1,487 $510,000
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $4,501 - $5,245	14 Added 0.98%	1,438 $526,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $20,753 - $23,650	70 Added 5.17%	1,424 $460,000
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $13,936 - $16,363	-50 Reduced 3.56%	1,354 $439,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $124,385 - $154,579	530 Added 60.64%	1,404 $402,000
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $196,518 - $243,880	874 New	874 $241,000

Others Institutions Holding LLY

# of Institutions

4,392

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $767B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.

Account